PATENT CLAIM ANALYSIS

Application Number: 16020436
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-05
Patent Classification: ["544", "278000"]

Abstract:
The present invention provides 3-[2-fluoro-5-(2,3-difluoro-6-methoxybenzyl-oxy)-4-methoxyphenyl]-2,4-dioxo- 1,2,3,4-tetrahydrothieno [3 ,4-d]pyrimidine-5-carboxylic acid choline salt having excellent solubility and storage stability.

Claim (Index 2):
The method of  claim 1 , wherein said compound is administered orally.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 94.0
- Lexical Diversity: 1.07407
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14867501', '15647911', '13577832', '12612943', '11824536']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7276016906718062
- 35 USC 102 Novelty (BERT): 0.455969942042362
- Combined Prediction Score: 0.7004385158088619
- Mean Citation Score: 152.63950200000005
- Max Citation Score: 196.22867
- Similarity Product: 191.77544650321656

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test